Complications Secondary to Hyperemesis Gravidarum (HG)

Hyperemesis Gravidarum (HG) is not self-limiting, and its impact can last a lifetime for mothers and their children. Until there is recognition of this fact and comprehensive, universal, effective treatment for all HG patients, every level of society will continue to face the costs of HG.

Read More

Dr. Fejzo was invited to speak at the Keystone Conference

Dr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world. 

Read More

HER Research Surveys

Be a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!

Read More

HER Genetic Research Presented at ASHG

What is the cause of hyperemesis gravidarum? Dr. Fejzo presented our team’s results from the largest ever genetic study of HG (7,197 HG cases and 178,953 controls) at the American Society of Human Genetics annual conference in Los Angeles on October 26, 2022.

Read More

BJOG publishes HER/USC study on the genetics of HG

The HER Foundation continues the breakthroughs with publication of “Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum” in BJOG.

Read More

HER Psychosocial Research

The HER Foundation’s breakthrough psychosocial study shows that Hyperemesis Gravidarum (HG) is not self limiting and has societal implications.

Read More
Dr. Marlena Fejzo

2021 HG Research: A Summary

2021 has been a busy year for HER research, and we’re finding answers to your questions about Hyperemesis Gravidarum (HG). We’ve had papers published and given presentations. We also have papers under review in scientific journals, abstracts being reviewed for presentation at ACOG, new studies being kicked-off, and we are continuing ongoing research projects.

Read More

HER Board Members Lead Study at USC

HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.

Read More

Marlena Fejzo, PhD, presents on HER’s genetic research at ASHG Annual Meeting 2021

Marlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).

Read More
mom and meds

Research Summary: Safety of Ondansetron (Zofran) in Pregnancy

Read the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.

Read More